Summary & Overview
HCPCS G8936: Documentation of ACE/ARB Therapy Ineligibility
HCPCS Level II code G8936 records clinician documentation that a patient is not an eligible candidate for ACE inhibitor or ARB therapy for clinical or patient-centered reasons. This designation matters nationally because ACE inhibitors and ARBs are widely recommended for multiple cardiovascular and renal indications; documenting ineligibility affects quality measurement, care planning, medication reconciliation, and claims processing. Accurate use of the code supports clinical records, helps explain deviations from guideline-directed therapy, and informs payers and auditors about appropriate exceptions.
Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of the code’s clinical context, typical settings where it is used, and the kinds of documentation that justify its application. The publication also covers common billing modifiers and payer coverage considerations, coding relatedness to quality measures, and operational implications for ambulatory practices and specialty clinics.
This summary provides a national perspective on the code’s purpose and operational use, the payers most relevant to claims, and the clinical situations that trigger its use. Data not available in the input is noted where applicable in detailed sections.
Billing Code Overview
HCPCS Level II code G8936 documents that the clinician recorded the patient was not an eligible candidate for angiotensin-converting enzyme (ACE) inhibitor or angiotensin receptor blocker (ARB) therapy. Reasons captured may include allergy, intolerance, pregnancy, renal failure attributable to ACE inhibitor, valvular disease (aortic or mitral), other medical reasons, or patient-centered reasons such as patient decline.
Service Type: Medication eligibility documentation / care coordination related to antihypertensive therapy
Typical Site of Service: Outpatient clinic, primary care, specialty cardiology or nephrology visits, or other ambulatory care settings where medication candidacy is assessed.
Clinical & Coding Specifications
Clinical Context
A 68-year-old male with a history of ischemic cardiomyopathy and hypertension presents for a routine cardiology follow-up. The clinician reviews medication history and documents that the patient is not an eligible candidate for angiotensin converting enzyme (ACE) inhibitor or angiotensin receptor blocker (ARB) therapy due to a documented history of angioedema related to prior ACE inhibitor exposure and stage 4 chronic kidney disease with hyperkalemia despite dietary measures. The clinician records the reason for nonuse (allergy/intolerance and renal contraindication), discusses alternative therapies and documents patient understanding. The encounter occurs in an outpatient cardiology clinic, with possible coordination by primary care or nephrology. The documentation supports billing of G8936 to indicate clinician-documented ineligibility for ACE inhibitor/ARB therapy.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | Use when substantial additional work beyond typical visit is documented (e.g., complex risk-benefit discussion regarding heart failure therapies). |
23 |